Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03333876 · ClinicalTrials.gov registry record · NA
In Home Assessment of Three Anti-Snoring Devices, a Cross Over Study
A NA study, sponsored by Philips Respironics.
- Completed
- Registry status
- NA
- Development phase
- 58
- Enrollment target
NCT03333876 is a NA study that has completed, run by Philips Respironics. The registered enrollment target is 58 participants.
The verdict
NCT03333876, a NA study, has completed, sponsored by Philips Respironics.
- COMPLETED
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
Study Summary
Silent Night is a solution for primary snorers to guide them to the proper anti-snoring solution. It consists of a mobile application, which had an intake questionnaire, guides users to one of three anti-snoring solutions; a nasal dilator called, Mute (Rhinomed, Australia), a mandibular advancement device called myTAP V (Airway Management, Austin, TX) and a Sleep Positional Trainer SPT (SPT) (NightBalance, Netherlands). The Silent Night app also records snoring through the night and provides feedback to the user via a "snore score."
Interventions
- DEVICE Nasal Dilator
- DEVICE Mandibular Advancement
- DEVICE Positional Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2017-10-09 |
| Est. Completion | 2017-12-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03333876
The ClinicalTrials.gov registry entry for NCT03333876 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philips Respironics, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Nasal Dilator is the first listed.
NCT03333876 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03333876 about?
NCT03333876 is a clinical study titled "In Home Assessment of Three Anti-Snoring Devices, a Cross Over Study". Silent Night is a solution for primary snorers to guide them to the proper anti-snoring solution. It consists of a mobile application, which had an intake questionnaire, guides users to one of three anti-snoring solutions; a nasal dilator called, Mute (Rhinomed, Australia), a mandibular advancement ...
What is the current status of trial NCT03333876?
This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2017-10-09. Estimated completion is 2017-12-03.
What interventions are being tested in trial NCT03333876?
The interventions under investigation include: Nasal Dilator (DEVICE), Mandibular Advancement (DEVICE), Positional Therapy (DEVICE).
Who is sponsoring clinical trial NCT03333876?
This trial is sponsored by Philips Respironics, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.